TGFBR2 and endometrial cancer: For instance, TGF-β receptor 2 (TGFBR2) was the first MSI gene to be identified, and several frameshift mutations leading to loss of function in this gene are seen in 80% of MSI-H CRCs, while less commonly so in endometrial cancers (Randrian et al., 2021).